Eiry Roberts, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 27,850 shares at $120.30 ($3.4M) on 2023-12-12, disclosed to the SEC on 2023-12-14.
Scheduled sale ($3.4M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.30 | 6,978 | $839K | 25.1% |
| 2 | $120.30 | 6,978 | $839K | 25.1% |
| 3 | $120.31 | 6,947 | $836K | 24.9% |
| 4 | $120.31 | 6,947 | $836K | 24.9% |
| Total | $120.30 avg | 27,850 | $3.4M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-04 | $445K | — | Filing → |
| NBIX | SELL | 2024-02-15 | $296K | — | Filing → |
| NBIX | SELL | 2024-02-08 | $582K | — | Filing → |